Novel near-infrared probe visualizes norepinephrine levels in Parkinson's disease, suggesting enhanced monitoring techniques.
Norepinephrine (NE), a key neurotransmitter, plays a crucial role in Parkinson's disease (PD). However, precise tracking NE dynamics during PD pathology remains a significant challenge. Herein, we develop a novel near-infrared chemiluminescent probe (CL-NE) that can visualize the dynamic changes of NE levels in brains experiencing PD. Benefiting from its excellent sensitivity and selectivity, the CL-NE probe is applied to monitor NE dynamics in neuronal cells. Notably, CL-NE successfully observed aberrantly expressed NE in MPTP-induced Parkinson's mouse brains. Overall, our study provides a powerful tool for in vivo NE monitoring, offering valuable insights to improve the pathogenesis, diagnosis, and therapy of PD.
No takes yet. Share an insight, caveat, or question.
Lv et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: